Chronic obstructive pulmonary disease (COPD) is a complex disease with many patients suffering from cardiovascular comorbidity. However, cardiovascular diseases remain often undiagnosed in COPD. Assessment of the retinal microvasculature can provide value in cardiovascular profiling of these patients. Retinal microvascular assessment carried out via a noninvasive eye exam represents an easy to use tool when examining patients with COPD. The purpose of this review was to provide an overview of studies assessing structural and functional changes in the retinal microvasculature of patients with COPD. Findings demonstrated that structural and functional microvascular changes were more common and severe in COPD patients as compared to non-COPD controls, although few retinal investigations have been performed in patients with COPD. As cardiovascular comorbidities are highly prevalent in COPD, we advocate more research to investigate the value of an eye exam for microvascular phenotyping of COPD patients.
ABSTRACT.
Chronic obstructive pulmonary disease (COPD) is a complex disease with many patients suffering from cardiovascular comorbidity. However, cardiovascular diseases remain often undiagnosed in COPD. Assessment of the retinal microvasculature can provide value in cardiovascular profiling of these patients. Retinal microvascular assessment carried out via a noninvasive eye exam represents an easy to use tool when examining patients with COPD. The purpose of this review was to provide an overview of studies assessing structural and functional changes in the retinal microvasculature of patients with COPD. Findings demonstrated that structural and functional microvascular changes were more common and severe in COPD patients as compared to non-COPD controls, although few retinal investigations have been performed in patients with COPD. As cardiovascular comorbidities are highly prevalent in COPD, we advocate more research to investigate the value of an eye exam for microvascular phenotyping of COPD patients. 
Background
Chronic obstructive pulmonary disease (COPD) is a respiratory condition characterized by persistent airflow limitation (Vogelmeier et al. 2017) . The global prevalence of COPD is approximately 11.7%, and COPD is estimated to become the fourth leading cause of death worldwide by 2030 (Mathers & Loncar 2006; Adeloye et al. 2015) . In the European Union, the annual costs of healthcare and lost productivity due to COPD are estimated as €48.4 billion. In addition, the social burden of COPD, estimated by disability adjusted life-years (DALYs) lost due to COPD, is another €93.0 billion per year (Gibson et al. 2013) .
The clinical diagnosis of COPD is based on spirometry, confirming a ratio of postbronchodilator forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) below 0.70 (Vogelmeier et al. 2017) . The severity of COPD can be graded according to the degree of airflow limitation into mild (FEV 1 /FVC < 70%; FEV 1 ≥ 80% predicted), moderate (FEV 1 /FVC < 70%; 50% ≤ FEV 1 < 80% predicted), severe (FEV 1 / FVC < 70%; 30% ≤ FEV 1 < 50% predicted) and very severe (FEV 1 / FVC < 70%; FEV 1 < 30% predicted) (Vestbo et al. 2013) . However, there is considerable heterogeneity between COPD patients, regarding respiratory symptoms, frequency of exacerbations, lung function decline, response to therapy and survival (Vestbo et al. 2013; Vogelmeier et al. 2017) . Therefore, the updated global initiative for chronic obstructive lung disease (GOLD) guidelines recommend to also determine the current level of patient's symptoms and the risk of exacerbation for classifying COPD patients (GOLD A: low risk, fewer symptoms; GOLD B: low risk, more symptoms; GOLD C: high risk, fewer symptoms; GOLD D: high risk, more symptoms) (Vestbo et al. 2013; Vogelmeier et al. 2017) .
It is increasingly recognized that comorbidities are highly prevalent, irrespective of severity of COPD (Barnes & Celli 2009; Vogelmeier et al. 2017) . These comorbidities contribute to the severity of symptoms and progression of the disease (Vogelmeier et al. 2017) . Cardiovascular diseases, including hypertension, coronary artery disease, heart failure, atrial fibrillation, stroke and peripheral arterial disease, are the most common comorbidities in COPD, with a prevalence ranging from 28% to 70% (Sin et al. 2005; Mullerova et al. 2013 ; Vanfleteren et al. 2013; Houben-Wilke et al. 2017; Vogelmeier et al. 2017) . Indeed, patients with COPD have a two to threefold increased risk of cardiovascular comorbidities compared to age-matched subjects when adjusting for sociodemographic factors and negative health behaviours including smoking (Finkelstein et al. 2009 ). However, cardiovascular comorbidities are often undiagnosed in patients with COPD, and therefore patients may not receive optimal treatment (Rutten et al. 2005; Houben-Wilke et al. 2016) . In this respect, an examination that integrates as much information as possible is important for developing and providing better methods to treat COPD and its comorbidities.
An eye exam may be a convenient tool to support early detection of cardiovascular disease in COPD (Figure 1) . The eye is the only place in the body that allows for a noninvasive and direct analysis of microvascular structure and function and provides the possibility to detect microvascular changes that relate to the development of cardiovascular disease (Flammer et al. 2013) . Indeed the retinal and choroidal microvasculature can be affected by many systemic diseases. Earlier cross-sectional and longitudinal studies in patients with increased cardiovascular risk, including patients with diabetes, hypertension, stroke and metabolic syndrome, have already demonstrated that the structural changes in the retinal and choroidal vasculature, measured by optical coherence tomography (OCT) and fundus photography, can serve as markers for cardiovascular disease, independently of traditional risk factors (Tedeschi-Reiner et al. 2005; Wong & Mitchell 2007; Liew et al. 2008; Mimoun et al. 2009; McClintic et al. 2010; Flammer et al. 2013; Ahmad et al. 2017; Gupta et al. 2017) . Indeed, thickness of the choroid, the vascular layer of the eye and retinal microvascular abnormalities, such as arteriolar narrowing, venular widening, decreased arteriovenous ratio (AVR) and suboptimal branching, are associated with hypertension and cardiovascular events, including stroke and coronary heart disease (Wong & McIntosh 2005; Liew et al. 2008; Flammer et al. 2013; Wong et al. 2013; Ahn et al. 2014; Altinkaynak et al. 2014; Ahmad et al. 2017) .
In addition, assessment of dynamic changes in retinal vessel diameter during flicker light stimulation can provide important functional information, as it is a measure of the vascular reactivity and reflects the endothelial function of the microcirculation (Heitmar & Summers 2012) . Dysfunction of the endothelium, represented by a reduced flicker light-induced vasodilatation, precedes the development of vascular changes, which can eventually result in cardiovascular events (Flammer et al. 2013 ). An impaired flicker lightinduced vasodilatation has already been demonstrated in patients with increased cardiovascular risk, such as diabetes, hypertension, obesity and dyslipidemia (Heitmar & Summers 2012; Lim et al. 2013) . Furthermore, dynamic assessment of the orbital vessels, using colour Doppler ultrasonography, has demonstrated that changes in blood flow velocity and resistive index (RI), are associated with various vascular disorders, and have clinical importance for the prediction of coronary artery disease (Tranquart et al. 2003; Maruyoshi et al. 2010) .
Structural and functional assessment of the vasculature of the eye is used in many epidemiological and clinical research settings and the aim of this paper is to bring together the information that is available on patients with COPD.
Materials and Methods
A computerized literature search was performed in Medline/PubMed, web of knowledge and Embase up to 30 September 2017. The keywords 'COPD e', 'microcirculation', 'microvessels', 'microvasculature', 'eye', 'retina', 'choroid', 'ocular', 'fundus', 'noninvasive', 'assessment', 'measurement' 'OCT', 'colour Doppler ultrasonography', 'fundus photography', 'retinal imaging', 'retinography', 'retinal oximetry', and derivatives of these were used in various combinations. Studies were included if they met the following criteria: (1) Participants: patients with COPD; (2) Outcome: microvasculature of the eye; (3) Methods: noninvasive assessment of microvasculature; no in vitro or ex vivo studies were included. Titles and abstracts were screened for inclusion criteria and potentially eligible articles were retrieved. References from these articles and previous reviews were also scanned for any other relevant articles. Non-English language articles, review articles, editorials, qualitative studies and congress abstracts were excluded. In addition, studies investigating solely the microvasculature in the lungs and/or other organs were excluded.
Our search identified 208 unique studies, of which 10 fulfilled eligibility criteria. Reasons for exclusion were as follows: not studying patients with COPD (n = 89) or microvasculature of the eye (n = 38), non-English articles (n = 46) and review articles or abstracts (n = 25). Details of study participants and relevant results are provided in Table 1 . Results of the study are classified according to the assessment method: OCT, retinal fundus imaging, retinal oximetry or colour Doppler ultrasonography.
Optical coherence tomography
Optical coherence tomography (OCT) allows obtaining high-resolution crosssectional images of the choroid (Jaffe & Caprioli 2004; Sakata et al. 2009; Adhi & Duker 2013) . The choroid is a highly vascular membrane that covers most of the posterior of the eye between the retina and sclera and has the highest blood flow per unit weight of any tissue in the body (Tan et al. 2016) . Although not consistently demonstrated, the thickness of the choroid has been suggested to reflect the choroidal blood flow, with choroidal thinning indicating a decreased choroidal blood flow and increased vascular resistance (Querques et al. 2012) . Evidence from earlier studies suggest that subfoveal choroidal thickness can provide indicative information regarding systemic cardiovascular health Ahn et al. 2014; Altinkaynak et al. 2014; Ahmad et al. 2017 ). In addition to OCT, recently OCT angiography (OCTA) has been introduced with a superior view to look at the microvasculature (Kashani et al. 2017; Tan et al. 2018) . The technique allows detailed study of flow within vascular structures of the eye and has the potential to improve diagnosis and monitoring of various retinal vascular abnormalities (Kashani et al. 2017; Tan et al. 2018 ). The research and clinical impact of OCTA are rapidly growing, but the technique has not been applied on patients with COPD (Kashani et al. 2017) .
Three studies evaluated the peripapillary choroidal thickness of patients with COPD (Table 1) (Ozcimen et al. 2016; Ugurlu et al. 2016; Gok et al. 2017) . Ozcimen et al. 2016) demonstrated that the peripapillary choroid in the inferior segments of patients with COPD was significantly thinner than other peripapillary choroid segments and also thinner than those of control patients. In COPD, choroidal thinning might be due to hypoxia and vascular endothelial dysfunction, making the choroid more susceptible to retinal and choroidal diseases (Ozcimen et al. 2016 ), but also systemic microvascular disorders (Tan et al. 2016 ). Although Ozcimen et al. did not find a difference in average peripapillary and subfoveal choroidal thickness of patients with COPD compared to controls. This is in line with findings from the study of Gok et al. (2017) , in which no significant difference was found in choroidal thickness of patients with mild to very severe COPD compared to matched controls. They also found no relationship between choroidal thickness and COPD severity (Gok et al. 2017 ). Ugurlu and coworkers reported no significant difference in choroid thickness between a group of male COPD patients and male controls (Ugurlu et al. 2016) . In addition, they also compared the diameter of the retinal vessels, which may have an independent role in cardiovascular risk prediction. (Ikram et al. 2004; Liew et al. 2008; Sun et al. 2008; De Boever et al. 2014) . The authors demonstrated that the retinal veins were significantly more dilated in the COPD group than in the control group. This might be attributed to the effects of smoking, chronic inflammation and hypoxia, as seen earlier in large population-based studies Wong et al. 2006; de Jong et al. 2008 ). The study did not observe an association between retinal vessel calibre and choroidal thickness on the one hand and COPD severity on the other hand, but the sample size was relatively small and more than half of the patient had severe COPD, while no patients had mild COPD (Ugurlu et al. 2016) .
Fundus photography
Retinal vascular calibre measured using fundus photography has been widely used as a marker for cardiovascular diseases (Mimoun et al. 2009; McClintic et al. 2010; Liew & Wang 2011) . Harris et al. (2012) examined the association between retinal microvascular changes and lung function using data from the Multi-Ethnic Study of Atherosclerosis (MESA), a multicenter prospective cohort study. Retinal vessel dimensions were expressed as central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE), representing the six largest arteries and the six largest veins within an area equal to 0.5-1 disc diameters from the optic disc margin (Harris et al. 2012 ). The authors demonstrated that among 3397 participants selected from the • There was no relationship between choroidal thickness and COPD severity
• • Cigarette exposure and chronic inflammation may contribute to microvascular disease Golpe et al. • There were significant positive correlations between retinal arterial and peripheral arterial oxygen saturation as assessed with pulse oximetry as well as between retinal arterial and peripheral arterial oxygen saturation measured in blood samples.
• The change in oxygen saturation after discontinuation of oxygen supplementation showed a good correlation between retinal arterial oxygen saturation and peripheral arterial oxygen saturation (r = 0.53; p < 0.05).
• Data show that the retinal arterial oxygen saturation as found in patients with severe COPD is well correlated to the readings of peripheral arterial oxygen saturation.
• general population, retinal venular diameter was inversely associated with FEV 1 and FEV 1 /FVC ratio, after adjusting for smoking and other potential confounders. Therefore, Harris and coworkers concluded that lung dysfunction may be characterized by defects in the microvascular circulation (Harris et al. 2012 ).
In the study of Chew et al., patients with COPD and controls underwent colour retinal photography of both eyes using a non-mydriatic retinal camera. Vessel diameters were expressed as CRAE and CRVE. In addition, microvascular retinopathy was classified as mild (arteriovenous nicking, focal arteriolar narrowing, silver-wiring or a decreased AVR), moderate (haemorrhage or exudates) or severe (papilledema) (Chew et al. 2016 ). Chew et al. observed wider retinal arterioles and venules in patients with COPD compared to controls. Retinal venular diameter was associated with increased cigarette exposure and inflammation (Chew et al. 2016 ). In addition, they showed that microvascular retinopathy was more common in patients with COPD compared to age-and gendermatched non-COPD controls. Both the mild and moderate retinopathy were more common in patients with COPD. Multivariate analyses also demonstrated that COPD remained an independent determinant of microvascular retinopathy after adjusting for hypertension, smoking, gender and diabetes (Chew et al. 2016) .
The increasing diameter of the retinal veins may be associated with chronic inflammation and hypoxia in COPD (Ugurlu et al. 2016) . Indeed, large population-based studies have already demonstrated the association between larger retinal venular calibre and hypoxia, systemic inflammation and smoking Wong et al. 2006; de Jong et al. 2008) . In this respect, it is recognized that wider retinal venular calibre is associated with risk of cardiovascular events and cardiovascular mortality, independent of traditional risk factors (Wang et al. 2006 (Wang et al. , 2007 Liew et al. 2008; McClintic et al. 2010) .
In addition to changes in retinal vessel diameters, AVR of retinal vessels is a generally used parameter. Decreased AVR represents generalized arteriolar narrowing and is frequently used in the assessment of different vascular diseases. (Hubbard et al. 1999; Wong et al. 2001 Wong et al. , 2004 Smith et al. 2004 ). Recent population-based studies demonstrated a strong association between decreased AVR and hypertension, coronary artery disease, diabetes and stroke (Wong et al. 2001 (Wong et al. , 2002a Wong et al. 2002b; Wong et al. 2004) . Golpe et al. (2016) determined the AVR in patients with COPD and non-COPD controls using the average of all vessel calibres measured at arterial and venous intersections (Hubbard et al. 1999) . They observed no significant difference in AVR between patients with COPD and controls (Golpe et al. 2016) .
Although AVR may serve as a marker of cardiovascular diseases, an important limitation is its inability to provide information of absolute measures of retinal arteriolar and venular calibre (Cheung & Wong 2007) . Both narrower arterioles and wider venules may produce a smaller AVR, and, consequently, the AVR cannot differentiate between changes in arteriolar and venular calibre. Differentiation between changes in arteriolar and venular calibre is important, as they are associated with different systemic diseases. Earlier population-based studies described a link between smaller retinal arterioles and hypertension, while wider retinal venules were associated with inflammatory markers, smoking, hyperglycaemia, obesity and dyslipidaemia (Smith et al. 2004; Wong et al. 2006) . So, changes in retinal arteriolar and venular calibre may reflect different pathophysiological processes, which cannot be disentangled using AVR (Cheung & Wong 2007) .
It should be recognized that static retinal imaging only reflects a snapshot of the retinal microvasculature and provides limited information on functional alterations of the vasculature (Heitmar & Summers 2012; Lim et al. 2013 ) Dynamic vessel analysis has the potential to continuously record images over a longer period of time. Flicker light stimulation can be used to provoke the retinal vessels to react, allowing assessment of the dynamic properties of retinal arterioles and venules (Heitmar & Summers 2012; Lim et al. 2013) . It is a measure of vascular reactivity and reflects the endothelial function of the microcirculation (Heitmar & Summers 2012 ).
Several
population-based studies demonstrated that dynamic vessel analyses could be a useful tool for studying microvascular function and may offer potential as a noninvasive research tool for cardiovascular risk prediction (Heitmar & Summers 2012; Lim et al. 2013; Sorensen et al. 2016) . Indeed, an impaired flicker light-induced vasodilatation has already been demonstrated in patients with increased cardiovascular risk, such as diabetes, hypertension, obesity and dyslipidemia (Lim et al. 2013; Sorensen et al. 2016) . Moreover, flicker light-induced vasodilation is significantly reduced in chronic smokers (Garhofer et al. 2011) . Interestingly, no data are available in patients with COPD.
Retinal oximetry
A retinal oximeter can be used assessment of oxygen saturation in larger retinal vessels based on the differential light absorbance of oxygenated and deoxygenated blood at specific wavelengths of light (Hardarson 2013) . Chronic obstructive pulmonary disease (COPD) is associated with hypoxia, especially when COPD severity increases. It is assumed that hypoxia is involved in the pathogenesis of cardiovascular diseases in COPD (MacNee et al. 2008; Maclay & MacNee 2013) . It is known that in the presence of hypoxia, vasoconstriction in peripheral vascular beds and redistribution of blood flow occur to preserve coronary, cerebral and ocular perfusion (Heistad & Abboud 1980) , resulting in less reliable measurements of peripheral oxygen saturation by pulse oximetry (Van de Louw et al. 2001; Wilson et al. 2010) . Therefore, measurement of oxyhaemoglobin saturation by retinal oximetry may be a more reliable and relevant method to determine organ oxygenation and hypoxia in patients with COPD than measurements of peripheral oxyhaemoglobin saturation (Heistad & Abboud 1980; Van de Louw et al. 2001; Wilson et al. 2010) . Eliasdottir et al. (2017) determined the blood oxyhaemoglobin saturation in the retinal vessels in patients with COPD, who were on long-term oxygen therapy based on the criteria for experiencing sustained hypoxia (defined as an arterial oxyhaemoglobin saturation of <90%), and healthy subjects. The authors demonstrated that retinal oximetry detected lower oxyhaemoglobin saturation in patients with COPD breathing ambient air compared to healthy controls (Eliasdottir et al. 2017) . Furthermore, they showed that retinal oximetry is able to capture an increase in retinal arteriole oxyhaemoglobin saturation when the COPD subjects inspired supplemental oxygen. These results are in line with findings from Palkovits et al. (2013) , who demonstrated that changes in systemic arterial oxygen saturation, as induced by the cessation of supplemental oxygen therapy, are well reflected in the changes of retinal arterial oxygen saturation in patients with COPD. Indeed, baseline retinal arterial oxygenation decreases significantly after withdrawal of oxygen (Palkovits et al. 2013) .
Although retinal oximetry is able to detect hypoxaemia in retinal vessels in patients with severe COPD and is sensitive to changes in oxygen breathing, implementation of the technique in clinical practice is complicated by the limited availability of the retinal oximeter. Further improvements and development of a hand-held device for realtime measurements of oxygen saturation levels will be needed for implementation of retinal oximetry in clinical practice.
Colour Doppler ultrasonography

Colour
Doppler ultrasonography assesses hemodynamic changes, such as peak systolic velocity (PSV), end diastolic velocity (EDV) and RI values of the orbital vessels (Williamson & Harris 1996) . Changes in PSV, EDV and RI are associated with various vascular disorders, and have predictive value for coronary artery diseases (Tranquart et al. 2003; Maruyoshi et al. 2010) . Three studies used colour Doppler ultrasonography with patients with COPD, showing an increased PSV, EDV, and RI values of the ophthalmic artery (OA), central retinal artery (CRA) and posterior ciliary artery (PCA) in patients with COPD compared to non-COPD control subjects (Ozer et al. 2006; Celik et al. 2014; Yakut et al. 2015) . Ozer et al. (2006) determined RI, pulsatility index (PI), PSV and EDV in the OA, CRA and PCA in 45 male patients with COPD and 17 male controls. Resistive index (RI) values provide data about vascular resistance. It is known that patients with COPD have increased plasma levels of endothelin-1 (ET-1), which is a powerful vasoconstrictor with significant systemic vascular effects (Roland et al. 2001; Polak et al. 2003) . Therefore, it was speculated that when ET-1 increase reaches critical levels, it causes vasospasm in ocular arteries, and vascular resistance increase within ocular arteries in COPD patients (Ozer et al. 2006) . Indeed, the authors observed significantly higher RI values of OA and CRA in patients with moderate and severe COPD compared to controls (Ozer et al. 2006 ). In addition, RI values of the lateral and medial PCA were significantly different between patients with moderate COPD and controls. No differences were found between patients with mild COPD and control subjects. Furthermore, Ozer et al. demonstrated a significantly higher PSV in the OA in patients with moderate and severe COPD and a tendency of higher PSV in mild stage COPD compared to the control group. This increased blood flow velocity may serve to compensate for the metabolic needs due to relative oxygen deficit caused by systemic hypoxia in COPD patients. Although no significant differences were found for other arteries. Moreover, the EDVs of the arteries did not differ significantly between patients with COPD and control group (Ozer et al. 2006) . Yakut et al. (2015) observed similar findings in 37 patients with COPD, 37 patients with asthma and 41 healthy controls. Resistive index (RI) values of the CRA, temporal PCA and nasal PCA were significantly higher in patients with COPD compared to controls. In addition, PSV and EDV were significantly higher. No differences were found between patients with COPD and patients with asthma (Yakut et al. 2015) .
In the study of Celik et al. (2014) , 60 patients with COPD patients with COPD and 35 control subjects were measured. Resistive index (RI) was more impaired in severe COPD patients compared control subjects, but also compared to patients with mild and moderate COPD. No significant differences were found between mild and moderate COPD patients and control subjects. Furthermore, no significant differences were found in PSV and EDV between patients with COPD and control subjects (Celik et al. 2014 ). However, it has been recognized that both PSV and EDV can be influenced by Doppler angle, whereas RI is independent of the Doppler angle (Platt et al. 1990) . Therefore, RI is assumed to be more suitable for the identification of vascular parameters.
Conclusions
Structural and functional assessment of the vasculature of the eye has provided useful information in a myriad of epidemiological and clinical research settings, with the ability to provide value for cardiovascular risk prediction. Cardiovascular risk factors (e.g. hypertension, obesity, diabetes) are usually preceded by changes in the microvasculature. A substantial number of patients suffering from COPD have microvascular complications and are at risk for diabetes and cardiovascular diseases. Considering the utility of retinal imaging in other clinical domains, we suggest to also consider retinal imaging for better phenotyping COPD patients (Figure 1 ). However, our systematic analysis suggests that this field is largely unexplored, and longitudinal studies assessing the association between microvascular changes in the eye and enhanced cardiovascular risk in COPD are lacking.
We identified four different methods for structural and functional assessment of the vasculature of the eye: OCT, retinal fundus imaging, retinal oximetry or colour Doppler ultrasonography. Available data suggest the presence of structural and functional microvascular changes in eyes of patients with COPD, including increased retinal venular calibre, lower retinal arterial oxygen saturation, impaired haemodynamics and increased RI of the orbital vessels. Results on choroidal thickness are contradictory. Authors speculated that the changes in microvasculature are related to systemic inflammation and hypoxia in COPD. Indeed, both systemic inflammation and hypoxia play a role in the pathogenesis of cardiovascular diseases. We advocate studies focusing on the characterization of the retinal microvasculature in patients with COPD, including validation using echocardiography and electrocardiogram and repeated assessments to establish stability over time. Moreover, assessment during COPD exacerbations resulting in hospitalizations is of interest as these exacerbations are associated with an increased cardiovascular mortality. Considering the high prevalence and incidence of cardiovascular comorbidity in COPD patients, and the fact that cardiovascular comorbidities are often undiagnosed, retinal imaging techniques might be valuables tools for further cardiovascular phenotyping of patients with COPD, which may lead to better patient stratification and more individualized treatments.
